Jeroen L A van Vugt
Overview
Explore the profile of Jeroen L A van Vugt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1043
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rom H, Tamir S, van Vugt J, Berger Y, Perl G, Morgenstern S, et al.
Ann Surg Oncol
. 2021 Oct;
29(3):1553-1563.
PMID: 34716836
Objective: To determine whether sarcopenia can potentially predict worse survival after resection of pancreatic ductal adenocarcinoma. Background: Sarcopenia is correlated with poor outcomes in hepatopancreatobiliary malignancies, but the relationship of...
12.
van Rees J, Visser E, van Vugt J, Rothbarth J, Verhoef C, van Verschuer V
BJS Open
. 2021 Oct;
5(5).
PMID: 34672343
Background: Pelvic exenteration for locally advanced rectal cancer (LARC) and locally recurrent (LRRC) rectal cancer provides radical resection and local control, but is associated with considerable morbidity. The aim of...
13.
Beumer B, Buettner S, Galjart B, van Vugt J, de Man R, IJzermans J, et al.
Eur J Surg Oncol
. 2021 Oct;
48(3):492-499.
PMID: 34602315
Background: Many prognostic models for Hepatocellular Carcinoma (HCC) have been developed to inform patients and doctors about individual prognosis. Previous reviews of these models were qualitative and did not assess...
14.
Waalboer R, Meyer Y, Galjart B, Olthof P, van Vugt J, Grunhagen D, et al.
HPB (Oxford)
. 2021 Sep;
24(1):9-16.
PMID: 34556406
Background: Sarcopenia is defined as either low pre-operative muscle mass or low muscle density on abdominal CT imaging. It has been associated with worse short-term outcomes after surgery for colorectal...
15.
van den Berg I, Coebergh van den Braak R, van Vugt J, IJzermans J, Buettner S
World J Surg Oncol
. 2021 May;
19(1):159.
PMID: 34039352
No abstract available.
16.
Vugts J, Gaspersz M, Roos E, Franken L, Olthof P, Coelen R, et al.
Ann Surg Oncol
. 2021 May;
28(Suppl 3):880.
PMID: 34018088
No abstract available.
17.
van den Berg I, Coebergh van den Braak R, van Vugt J, IJzermans J, Buettner S
World J Surg Oncol
. 2021 Apr;
19(1):96.
PMID: 33820567
Background: Colorectal cancer is the third most common type of cancer in the world. We characterize a cohort of patients who survived up to 5 years without recurrence and identify...
18.
Bot D, Droop A, Lucassen C, van Veen M, van Vugt J, Feshtali S, et al.
Clin Nutr ESPEN
. 2021 Mar;
42:272-279.
PMID: 33745592
Background And Aims: Malnutrition is highly prevalent in patients with end-stage liver disease (ESLD) and associated with impaired clinical outcome. Previous studies focused on one component of body composition and...
19.
van Doorn L, Crombag M, Rier H, van Vugt J, van Kesteren C, Bins S, et al.
Pharmaceuticals (Basel)
. 2021 Jan;
14(1).
PMID: 33435449
Changes in body composition are associated with chemotherapy-related toxicities and effectiveness of treatment. It is hypothesized that the pharmacokinetics (PK) of chemotherapeutics may depend on body composition. The effects of...
20.
Smoor R, Kropman R, Brouwers S, van Vugt J, Wille J, van Klei W, et al.
Eur J Vasc Endovasc Surg
. 2020 Oct;
61(1):169-170.
PMID: 33067109
No abstract available.